Duty Stuart 4

4 · EyePoint Pharmaceuticals, Inc. · Filed Jan 9, 2024

Insider Transaction Report

Form 4
Period: 2024-01-05
Duty Stuart
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-01-05+25,01425,014 total
    Exercise: $20.40From: 2025-01-05Exp: 2034-01-04Common Stock (25,014 underlying)

Documents

1 file
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT